This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Osteopontin (OPN), N-His-SUMO
Product Overview
BioVenic's Recombinant Canine Osteopontin (OPN), N-His-SUMO is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 44 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
Osteopontin (OPN) is a bone sialoprotein that facilitates osteoclast attachment to the mineralized bone matrix and acts as a bone matrix protein. Research indicates that OPN may represent a promising target for future studies on canine mammary gland tumors and prostate cancer, owing to its role in promoting cell invasion and metastasis.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10 mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Grisoni Sanchez, Caroline et al. "Is Osteopontin a Good Marker for Bone Metastasis in Canine Mammary Gland Tumor and Prostate Cancer?." Animals : an open access journal from MDPI vol. 13,20 32114 Oct. 2023